Radio interview on 3RRR Einstein A Go-Go- Diabetes researcher Melinda Coughlan shares findings of a drug which can decrease kidney injury in diabetes patients.

Press/Media: Profile/Interview


Radio interview on 3RRR Einstein A Go-Go on 3rd November 2019. Dr Shane and I discuss my latest work in which my group identified a potential new therapy to slow the development of diabetic kidney disease. Inhibition of the Complement 5a receptor is responsible for inflammation and renal fibrosis and the new drug PMX-53 is protective to the kidneys in the diabetic setting. 

Period3 Nov 2019

Media contributions


Media contributions